News About: Pharm. Industry
Kyung Nam Pharm accepts court’s rejection of the largest shareholder’s Request for Preliminary Injunction against New Stock Issuance
As the Request for Preliminary Injunction against New Stock Issuance filed by the largest stockholder Mr. Hee-Cheol Lee against Kyung Nam Pharm, the Kyung Nam Pharm’s conflict between the company and the largest stock...
Daewoong Pharmaceutical and Medytox focusing on taking superiority in global market aside from the legal suit
Having conflicts over the botulinum toxin strain issue, Daewoong Pharmaceutical and Medytox are going on a new direction.
Thinking ‘taking a step backward is losing; so far, they have taken a ‘truth or dare’ game wit...
No. 1 & 2 pharmaceutical companies Yuhan Corporation and GC Pharm gather for new drug development
Two of the largest pharmaceutical companies will take barnstorming sessions to develop orphan drugs.
GC Pharm and Yuhan Corporation announced on the 19th that they signed a memorandum of understanding to jointly deve...
US FDA starts to assess Celltrion’s Herzuma approval
Celltrion will resume the U.S. approval acquisition process as completing submission of additional documents to the FDA for ‘Herzuma,’ an antibody biosimilar for breast cancer.
Celltrion announced the company officia...
31 innovative pharma certificate to be extended until 2021 including CJ HealthCare
31 innovative pharmaceutical companies whose certificate will be expiring soon will keep the status for 3 more years by 2021.
The new 3 year will be applied by the new and stricter ethical and rebate standards in the...
Kolon Life Science acquire approval of tumor killing virus therapy
Kolon Life Science(CEO Woo-Seok Lee) announced on the 15th that the company acquired a patent of the poxvirus promoter,’ the company’s next pipeline that increases efficacy of the oncolytic virus treatment(also known ...
Huons & KRICT’s co-development agreement of targeted liver disease therapy
Huons(CEO Ki-Ahn Um) will take joint development of a new drug for liver diseases with the Korea Research Institute of Chemical Technology.
Huons and the Korea Research Institute of Chemical Technology(KRICT) announc...
Huons signs KRW 119.8 billion export agreement of Hutox with Brazil and Iran
Huons(CEO Ki-Ahn Um) announced on the 14th that they signed a supply agreement of total KRW 119.8 billion ‘Hutox(HU-014)’ products with Brazilian and Iranian aesthetic companies.
The agreement is followed by the supp...
SNS contents becoming great sources of marketing for pharmas
The pharmaceutical industry are catching consumers’ eyes with SNS contents as much as like TV advertisements. Their short clips and interesting images have promoted consumers to purchase products with big smiles and s...
Unexpected impacts of the 52 Weekly Working Hour Program into pharmaceutical industry
A revision to the Labor Standards Act which cuts weekly working hours to 52 hours has made concerns among pharmaceutical companies counting for the enforcement.
Even through the enforcement will partially impact the ...
